Investing
4 Stocks to Watch From the Prospering Business-Software Services Industry
The Zacks Business-Software Services industry is benefiting from the heightened demand for digital transformation and the ongoing shift to the cloud. The growing automation ...
What’s in Store for Landstar System (LSTR) in Q1 Earnings?
Landstar System Inc LSTR is scheduled to report first-quarter 2024 results on Apr 24 after market close. The company has an encouraging earnings history, having surpassed the ...
Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
Vertex Pharmaceuticals Incorporated VRTX announced that it has entered into a licensing and collaboration agreement with France-based biotech company, TreeFrog Therapeutics, to optimize the production ...
Will Higher Software Revenues Benefit IBM’s Q1 Earnings?
International Business Machines Corporation IBM is scheduled to report first-quarter 2024 results on Apr 24, after the closing bell. In the to-be-reported quarter, the ...
Globe Life (GL) Q1 Earnings Miss Estimates, Revenues Rise Y/Y
Globe Life Inc.’s GL first-quarter 2024 net operating income of $2.78 per share missed the Zacks Consensus Estimate by 0.7%. The bottom line improved ...
Zions (ZION) Stock Up 3.5% on Q1 Earnings Beat, Provisions Dip
Shares of Zions Bancorporation ZION gained 3.5% in response to better-than-expected first-quarter 2024 results. Adjusted net earnings per share of $1.03 surpassed the Zacks ...
Brown & Brown (BRO) Q1 Earnings & Revenues Surpass Estimates
Brown & Brown, Inc.’s BRO first-quarter 2024 adjusted earnings of $1.14 per share beat the Zacks Consensus Estimate by 6.5%. The bottom line increased ...
Altair (ALTR) Buys Cambridge Semantics, Enhances AI Technology (Revised)
In a bid to enhance its strong analytics and data science team with deep data warehousing expertise, Altair Engineering Inc. ALTR has acquired Cambridge ...
Will Alkermes’ (ALKS) Proprietary Drugs Aid Amid Competition?
Alkermes plc ALKS has made steady progress with its portfolio of proprietary products — Vivitrol (alcohol and opioid dependence), Aristada (schizophrenia) and Lybalvi (schizophrenia ...
Should You Buy STERIS (STE) Stock Ahead of Q4 Earnings?
STERIS plc STE is expected to release fourth-quarter fiscal 2024 results soon. Earnings Surprise History STE has a strong earnings surprise history. The company beat ...
